• Subscribe
  • Magazine
  • Videos
  • Advertise
  • About Us
  • Smart Water Summit
  • Wastewater Summit
    • Recent Quotes
    My Watchlist
    Indicators
    WaterWorld Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Capricor Therapeutics, Inc. - Common Stock (NQ:CAPR)

    27.91 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EST, Feb 24, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,407
    Open 27.91
    Bid (Size) 28.00 (300)
    Ask (Size) 29.80 (300)
    Prev. Close 27.91
    Today's Range 27.91 - 27.91
    52wk Range 4.300 - 40.37
    Shares Outstanding 45,711,975
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Capricor Or Sarepta: Two DMD Stocks Enter A High-Stakes Week – Which One Has More Upside? ↗
    Capricor is approaching a regulatory filing timeline and earnings, while Sarepta heads into results under legal and safety pressure. 
    Via Stocktwits
    News headline image
    Nasdaq, S&P 500 Futures Fall On Tariff, Iran Tensions: Why NVDA, NFLX, HON, IBRX, MLTX Are On Traders' Radar Today ↗
    Data from Stocktwits indicated retail sentiment on SPY and QQQ has been ‘bearish’. 
    Via Stocktwits
    Topics Artificial Intelligence ETFs Government

    Performance

    YTD
    -1.4%
    -1.4%
    1 Month
    +18.2%
    +18.2%
    3 Month
    +506.7%
    +506.7%
    6 Month
    +331.4%
    +331.4%
    1 Year
    +93.1%
    +93.1%

    More News

    Read More
    News headline image
    CAPR Stock Rallied Nearly 30% So Far This Week — Here’s The February FDA Catalyst Investors Are Betting On ↗
    Via Stocktwits
    ‘Pharma Bro’ Martin Shkreli Goes Short On Capricor Therapeutics – Stock Tumbles 17% ↗
    Via Stocktwits
    Capricor Therapeutics Stock Jumps After-Hours As Retail Cheers Fresh FDA Attempt After Duchenne Therapy Rejection ↗
    Via Stocktwits
    Tesla Chair Declares Start Of 'Whole New Book' As Musk's 423 Million Share Award Is Locked In — All Hope Pinned On Robotaxi, Optimus ↗
    Via Stocktwits
    News headline image
    Earnings Scheduled For November 10, 2025 ↗
    Via Benzinga
    News headline image
    CAPR Stock Slides After FDA Requests More Data For Genetic Disorder Therapy — What Does Retail Think? ↗
    Via Stocktwits
    News headline image
    Here's Why This Biotechnology Skyrocketed by 439% in December ↗
    Via The Motley Fool
    News headline image
    On Friday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Let's take a look at the stocks that are in motion in today's session. ↗
    Via Chartmill
    News headline image
    Preview: Capricor Therapeutics's Earnings ↗
    Via Benzinga
    News headline image
    Capricor’s Red-Hot Rally Has Wall Street And Retail Hooked — And Fresh DMD Data Could Keep Fueling The Fire ↗
    Via Stocktwits
    News headline image
    Capricor Therapeutics (NASDAQ: CAPR) Soars 535% to Eight-Year High on Landmark Duchenne Muscular Dystrophy Treatment Results
    Via MarketMinute
    News headline image
    ‘Pharma Bro’ Martin Shkreli Calls His Capricor Therapeutics Short A 'Bad Call' After DMD Trial Delivers Surprise Win ↗
    Via Stocktwits
    News headline image
    Why Did Capricor Therapeutics Stock Skyrocket Today? ↗
    Via Stocktwits
    News headline image
    Get insights into the top gainers and losers of Wednesday's pre-market session. ↗
    Via Chartmill
    News headline image
    Nasdaq, S&P 500 Futures Point To Steady Open: Why CAPR, MRVL, AEO, GTLB, CRWD Are On Traders' Radar ↗
    Via Stocktwits
    Topics Artificial Intelligence ETFs Economy
    News headline image
    Capricor Therapeutics Stock Sparks Retail Frenzy As Traders Hail ‘Best Data’ Ahead Of DMD Data Readout ↗
    Via Stocktwits
    News headline image
    Which stocks are experiencing notable movement on Monday? ↗
    Via Chartmill
    News headline image
    Top movers in Monday's session ↗
    Via Chartmill
    News headline image
    Top Stocks With Earnings This Week: Plug, Oklo, Circle And More ↗
    Via Benzinga
    News headline image
    Capricor Therapeutics Stock Becomes Talk Of Retail Town On DMD Study; Retail Sees New Hope After Sarepta Setback ↗
    Via Stocktwits
    News headline image
    CAPRICOR INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. Continues Investigation into Capricor Therapeutics, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
    From Bragar Eagel & Squire
    Via GlobeNewswire
    News headline image
    Why Capricor Therapeutics Stock Is Surging Today ↗
    Via Benzinga

    Frequently Asked Questions

    Is Capricor Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Capricor Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Capricor Therapeutics, Inc. - Common Stock trade on?
    Capricor Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Capricor Therapeutics, Inc. - Common Stock?
    The ticker symbol for Capricor Therapeutics, Inc. - Common Stock is CAPR on the Nasdaq Stock Market
    What is the current price of Capricor Therapeutics, Inc. - Common Stock?
    The current price of Capricor Therapeutics, Inc. - Common Stock is 27.91
    When was Capricor Therapeutics, Inc. - Common Stock last traded?
    The last trade of Capricor Therapeutics, Inc. - Common Stock was at 02/24/26 04:00 PM ET
    What is the market capitalization of Capricor Therapeutics, Inc. - Common Stock?
    The market capitalization of Capricor Therapeutics, Inc. - Common Stock is 1.28B
    How many shares of Capricor Therapeutics, Inc. - Common Stock are outstanding?
    Capricor Therapeutics, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.